⚕️ The information below is for educational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
When GLP-1 medications are discussed in the context of fertility and family planning, the conversation almost always focuses on women. But men have questions too — and the answers are medically important, especially in India where male infertility is underdiagnosed, male obesity rates are rising sharply, and the societal pressure to have children is significant.
This guide addresses what Indian men need to know about GLP-1 medications and reproductive health before starting treatment.
Consult your healthcare provider before starting any medication. If you and your partner are trying to conceive, disclose this to your prescribing doctor before beginning GLP-1 therapy.
Before discussing GLP-1 medications specifically, it is essential to understand the existing relationship between obesity and male reproductive health — because this is the starting point for most men who are prescribed GLP-1.
Obesity impairs testosterone production. Fat tissue, particularly abdominal visceral fat (the kind that accumulates around internal organs), contains an enzyme called aromatase that converts testosterone into oestrogen. The more visceral fat you have, the more testosterone is converted — leaving less available for the body to use. Studies show that obese men have significantly lower total and free testosterone compared to normal-weight men of the same age.
Low testosterone in men causes:
Obesity also directly impairs sperm quality. Research shows that obese men have higher rates of:
This means that for many obese or overweight Indian men, the underlying obesity is already harming their fertility before they even consider medication.
The most significant effect of GLP-1 medications on male reproductive health is indirect — through weight loss. Multiple studies confirm that significant weight loss in obese men dramatically improves testosterone levels. A landmark 2014 study in the Journal of Clinical Endocrinology and Metabolism showed that obese men who lost 10% of body weight saw testosterone levels rise by 25–30%.
For many Indian men on GLP-1, losing 8–12 kg over 6–12 months can bring testosterone from the low-normal or below-normal range into a healthy range — with corresponding improvements in energy, libido, mood, and sperm quality.
Interestingly, GLP-1 receptors are found in the testis, the hypothalamic-pituitary axis (the brain regions that regulate testosterone production), and the accessory reproductive glands. This means GLP-1 medications may have direct effects on male reproductive biology — not just indirect effects through weight loss.
A 2023 study published in Diabetes, Obesity and Metabolism found that semaglutide treatment was associated with improvements in testosterone levels and sexual function scores in obese men with type 2 diabetes, beyond what would be expected from weight loss alone. However, the research is preliminary — larger, dedicated studies are still needed.
On the caution side:
Animal studies have shown GLP-1 receptors in Sertoli cells (which support sperm development) and Leydig cells (which produce testosterone). In some rodent models, high-dose GLP-1 receptor agonists affected testicular function. However, these effects have not been demonstrated in human clinical trials at therapeutic doses.
The SUSTAIN and STEP trials of semaglutide did not specifically study sperm parameters or fertility outcomes in male participants. This is a genuine evidence gap.
Rapid calorie restriction — which many men experience in the first months on GLP-1 — can temporarily lower testosterone. Ensure adequate calorie and protein intake; extremely aggressive restriction is counterproductive for hormonal health.
The current medical consensus: The weight loss benefits of GLP-1 medications are likely to improve, not harm, male fertility in obese men. However, direct sperm quality data in humans is limited, and men actively trying to conceive should discuss this with a specialist.
Male infertility in India is significantly underdiagnosed. Cultural factors — shame, the assumption that infertility is a female problem, reluctance to undergo semen analysis — mean that many Indian men with fertility issues go unassessed for years. Key points relevant to GLP-1 users in India:
Male obesity rates are rising rapidly. The National Family Health Survey (NFHS-5) shows that 22.9% of Indian men aged 15–49 are now overweight or obese — up from 18.9% in NFHS-4. Many of these men are at risk of hypogonadism (low testosterone).
Diabetes and male fertility. Diabetes — the primary indication for many Indian men who receive GLP-1 medications — independently impairs sperm quality, ejaculatory function, and testosterone. GLP-1 medications used to treat diabetes may thus doubly benefit reproductive health.
Cost of a semen analysis in India is ₹400–₹1,200 at most pathology labs (SRL, Dr Lal, Metropolis). If you are trying to conceive, this baseline test is worth having before and during GLP-1 treatment.
If you and your partner are actively trying to conceive, or plan to in the next 1–2 years, tell your doctor before starting GLP-1. This changes the risk-benefit calculation and may affect which medication is chosen, at what dose, and for how long.
Before starting GLP-1, ask your doctor to check:
This gives you a baseline to compare against after 6–12 months on GLP-1 and weight loss.
If fertility is a concern, request a semen analysis (spermogram) at the start of GLP-1 treatment. Parameters to look for:
Extremely low calorie intake (below 1,200 kcal/day) or very low protein can suppress the hypothalamic-pituitary-gonadal axis and temporarily lower testosterone. On GLP-1, your appetite may be very suppressed — but prioritise getting 1.0–1.2 g protein/kg/day at minimum.
India-appropriate protein sources: paneer, dahi, dal, eggs, chicken, fish, soya chunks.
Weight training is one of the most evidence-backed ways to raise testosterone naturally. It also preserves muscle mass during weight loss — preventing the muscle-to-fat-ratio worsening that can lower testosterone further. Even 3 sessions per week of basic bodyweight exercises or gym training makes a significant difference.
After 6 months on GLP-1 with meaningful weight loss (5–10% of body weight), recheck your testosterone panel. Most men see significant improvement at this point.
Stopping GLP-1 abruptly if trying to conceive. Some men stop their medication without telling their doctor, hoping it helps fertility. Abrupt stopping can cause rapid weight regain, which worsens testosterone. Discuss any planned treatment changes with your doctor.
Assuming the problem is the medication, not the obesity. In most obese men, the obesity is the greater fertility threat. GLP-1 medications are likely to help, not hurt.
Not telling a fertility specialist you are on GLP-1. If you see an andrologist or urologist for fertility, bring your GLP-1 prescription. They need this information to interpret your hormone results correctly.
Testosterone replacement therapy without trying GLP-1 first. Some Indian doctors prescribe testosterone supplements for low testosterone without addressing the underlying obesity. Exogenous testosterone can actually suppress sperm production (by shutting down the hypothalamic-pituitary axis). Weight loss through GLP-1 is a more sustainable path to improving testosterone and fertility simultaneously.
Q: Can I take GLP-1 and father a child at the same time?
A: There is no human data showing that GLP-1 medications at therapeutic doses reduce sperm quality or cause birth defects through paternal exposure. Current guidance does not recommend stopping GLP-1 in men who are trying to conceive — but discuss with your doctor, who may want to monitor your hormone levels.
Q: Will losing weight on GLP-1 improve my testosterone?
A: Very likely yes. The evidence linking weight loss to testosterone improvement in obese men is strong and consistent. Most men who lose 8–12 kg see meaningful testosterone increases.
Q: My doctor prescribed testosterone alongside GLP-1 for low testosterone. Is this appropriate?
A: Testosterone replacement therapy (TRT) can worsen fertility by suppressing sperm production. If you want to father children in the future, discuss this risk explicitly with your doctor before starting TRT. In many cases, losing weight through GLP-1 can restore testosterone naturally without the need for TRT.
Q: I have type 2 diabetes and low testosterone. Will semaglutide help both?
A: Preliminary evidence suggests semaglutide may improve testosterone levels in men with obesity and type 2 diabetes, both through weight loss and potentially through direct hormonal effects. This is an active area of research.
This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for personalised guidance on fertility and hormonal health.
